News Conference News TCT 2025 At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I Yael L. Maxwell November 07, 2025
News Conference News TCT 2025 Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2 Todd Neale November 03, 2025
News Conference News TCT 2025 INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time Michael O'Riordan October 29, 2025
News Conference News TCT 2025 iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI Yael L. Maxwell October 28, 2025
News Conference News TCT 2025 PROCTOR: PCI of Failed Bypass Grafts Tops Native-Vessel PCI, With Caveats Todd Neale October 28, 2025
News Conference News TCT 2025 STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus Michael O'Riordan October 28, 2025
Presentation TCT 2025 Two Stents at the Bifurcation: Tailoring Your Technique Presenter: Kefei Dou October 28, 2025
Presentation TCT 2025 Provisional Left Main Stenting: Contemporary Considerations Presenter: Duk-Woo Park October 28, 2025
Presentation TCT 2025 Randomized Comparison of the Supraflex CruzTM vs. SYNERGYTM Drug-Eluting Stents: The Multivessel TALENT Randomized Trial Presenter: Patrick W. Serruys October 28, 2025
Presentation TCT 2025 TCT 513: Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Treatment for Single De Novo Diffuse Coronary Lesions Presenter: Eun-Seok Shin October 28, 2025
Presentation TCT 2025 TCT 1271: Safety and Efficacy of Biodegradable Polymer-coated Sirolimus-eluting Stent in the Treatment of Octo- and Nonagenarian All Comer Patients with Coronary Artery Disease – Results from the Prospective Multicenter Cruz Senior Study Presenter: Gregor Nelles October 28, 2025
Presentation TCT 2025 TCT 243: Innovative Iron-based Biodegradable Metal Coronary Stent Presenter: Jian Xie October 28, 2025
Presentation TCT 2025 TCT 963: Ethnic Disparities in Inflammatory Phenotype and CV Outcomes After Drug-Eluting Stent Implantation: A Multiethnic Perspective Presenter: Kyung-Taek Park October 28, 2025
Presentation TCT 2025 TCT 245: Final 7-Year Results from the COMPARE-ABSORB Trial: Randomized Comparison of Bioresorbable Vascular Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis. Detailed analysis of long lesions Presenter: Robert-Jan Van Geuns October 28, 2025
Presentation TCT 2025 TCT 619: Validation of Novel Endpoint for Optimal Drug-eluting stent Implantation in Patients with Acute Coronary Syndrome Presenter: Hisaki Masuda October 28, 2025
Presentation TCT 2025 TCT 1957: Improved Outcomes for In-Stent Restenosis PCI With Use of Sirolimus Eluting Ultra-thin Stent Platform Presenter: Jared Romeo October 28, 2025
Presentation TCT 2025 TCT 892: A prospective, open-labelled, multicentre, observational registry of ISAR SUMMIT in CAD patients undergoing PCI in real world Indian population. Presenter: Sameer I. Dani October 28, 2025
Presentation TCT 2025 TCT 1281: Systematic two-stent versus provisional stenting in patients with true coronary artery bifurcation lesions: A pooled individual patient-level meta-analysis of randomized trials Presenter: Shao-Liang Chen October 28, 2025
Presentation TCT 2025 TCT 891: Safety and clinical performance of the Yukon Choice PC, Yukon Chrome PC & Yukon Choice Flex Sirolimus Eluting Bioabsorbable Polymer Stents Systems in Routine Clinical Practice: e-Yukon Global Registry. Presenter: Bimmer E. Claessen October 28, 2025